Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • IMPAX LABORATORIES INC Income Statement

  • View:
    Annual Data | Quarterly Data
    Period Ending FY FY FY FY FY
    Net Sales/Revenues 210.07 M — — — —
    Cost of Goods Sold (Excluding Depreciation) 82.07 M — — — —
    Depreciation, Depletion and Amortization 9.90 M — — — —
    Gross Income — — — — —
    Selling, General & Admin Expenses 106.31 M — — — —
    Other Operating Expense 0.00 — — — —
    Operating Expenses - Total 32.21 M — — — —
    Operating Income 11.80 M — — — —
    Extraordinary Credit - Pretax 2.55 M — — — —
    Extraordinary Charge - Pretax 7.87 M — — — —
    Non-operating Interest Income 4.22 M — — — —
    Reserves Inc (Dec) — — — — —
    Pretax Equity in Earnings — — — — —
    Other Income/Expenses - Net 21.58 M — — — —
    Earnings Before Interest & Taxes (EBIT) — — — — —
    Interest Expenses On Debt 2.60 M — — — —
    Interest Capitalized 0.00 — — — —
    Pretax Income 29.67 M — — — —
    Income Taxes 10.97 M — — — —
    Current Domestic Income Tax 6.25 M — — — —
    Current Foreign Income Tax 0.00 — — — —
    Deferred Domestic Income Tax 4.72 M — — — —
    Deferred Foreign Income Tax 0.00 — — — —
    Income Tax Credits — — — — —
    Minority Interest — — — — —
    Equity in Earnings — — — — —
    After Tax Income Expense 0.00 — — — —
    Discontinued Operations — — — — —
    Net Income Before Extra Items/Preferred Div 18.70 M — — — —
    Extra Items & Gain (Loss) Sale of Assets — — — — —
    Net Income Before Preferred Dividends — — — — —
    Preferred Dividend Requirements 0.00 — — — —
    Net Income Available to Common — — — — —